# FDA 483 - Carl P. Griffin, M.D. - November 17, 2023

Source: https://www.keypedia.com/records/483/carl-p-griffin-md/5e0fa7fa-807e-46ab-adf9-1b020127934d

> FDA 483 for Carl P. Griffin, M.D. on November 17, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Carl P. Griffin, M.D.
- Inspection Date: 2023-11-17
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Carl F. Griffin, M.D. in Oklahoma City, a clinical investigator, revealed a significant issue regarding the conduct of an investigation. Specifically, the firm failed to properly review, verify, and evaluate subject diary entries for unsolicited Adverse Events as required by the investigational plan and protocol. This indicates a lapse in adherence to established research procedures.

## Related Officers

- [Habacuc V. Barrera](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)
- [Terri E. Gibson](https://www.keypedia.com/people/terri-e-gibson/f1a80f95-a5c4-4cae-9a4b-e23f367770bb)

Company: https://www.keypedia.com/companies/carl-p-griffin-md/5b14aec8-5b8b-4da2-ad58-8a1980a45cc9

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab